CLINICAL_TRIALS
trial_result
· 2018-10-23
Clinical Trial Update: Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma [Phase 3]
Summary
Phase 3 clinical trial evaluating dupilumab in severe steroid-dependent asthma has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2018-10-23